{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2020-06-10T10:56:11.066766Z",
     "start_time": "2020-06-10T10:56:11.027717Z"
    },
    "colab": {},
    "colab_type": "code",
    "id": "0zJFP1aI1Vj8"
   },
   "outputs": [],
   "source": [
    "from tika import parser\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2020-06-10T10:56:20.977610Z",
     "start_time": "2020-06-10T10:56:20.503642Z"
    },
    "colab": {},
    "colab_type": "code",
    "id": "Li0W7yr91Zgj"
   },
   "outputs": [],
   "source": [
    "raw = parser.from_file(\"data/1-s2.0-S0161813X18302092-main.pdf\")\n",
    "pdf_text=raw['content']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2020-06-10T10:56:32.575341Z",
     "start_time": "2020-06-10T10:56:32.559712Z"
    },
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 54
    },
    "colab_type": "code",
    "id": "le32E1FZ1gRH",
    "outputId": "9f8d76ee-f1c8-4916-958a-36d6887c9858"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice\n",
      "\n",
      "\n",
      "Contents lists available at ScienceDirect\n",
      "\n",
      "Neurotoxicology\n",
      "\n",
      "journal homepage: www.elsevier.com/locate/neuro\n",
      "\n",
      "Full Length Article\n",
      "\n",
      "Does nicotine impact tramadol abuse? Insights from neurochemical and\n",
      "neurobehavioral changes in mice\n",
      "\n",
      "Shimaa M. Azmya, Mai A. Abd El fattahb, Sahar S. Abd El-Rahmanc, Somia A. Nadad,\n",
      "Omar M.E. Abdel Salame, Mohammed F. El-Yamanyb, Noha N. Nassarb,⁎\n",
      "\n",
      "a Analytical Toxicology Laboratory, Forensic Medicine Authority, Cairo, Egypt\n",
      "b Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt\n",
      "c Pathology Department, Faculty of Veterinary Medicine, Cairo University, Egypt\n",
      "d Pharmacology Department, National Research Center, Giza, Egypt\n",
      "e Toxicology and Narcotics Department, National Research Center, Giza, Egypt\n",
      "\n",
      "A R T I C L E I N F O\n",
      "\n",
      "Keywords:\n",
      "Nicotine\n",
      "Tramadol\n",
      "Dopamine\n",
      "Dependence\n",
      "Memory\n",
      "Anxiety\n",
      "\n",
      "A B S T R A C T\n",
      "\n",
      "Nicotine and tramadol concomitant drug dependence pose increasing social, economic as well as public threats.\n",
      "Accordingly, the present study investigated neurochemical, neurobehavioral and neuropathological changes in\n",
      "the brain subsequent to the interaction of nicotine and tramadol. To this end, tramadol (20mg/kg, i.p) and\n",
      "nicotine (0.25mg/kg, i.p) were administrated to male albino mice once daily for 30 days. Consequent to mi-\n",
      "croglial activation, nicotine exacerbated oxidative/nitrosative stress induced by tramadol as manifest by the\n",
      "step-up in thiobarbituric acid reactive substances and nitric oxide subsequent to the enhanced levels of neuronal\n",
      "and inducible nitric oxide synthases; paralleled by decreased non-protein sulfhydryls. Increased oxidative stress\n",
      "by tramadol and/or nicotine sequentially augmented nuclear factor kappa B and the proinflammatory cytokine\n",
      "tumor necrosis factor α with the induction of apoptosis evident by the increased caspase-3 immunoreactivity.\n",
      "However, paradoxical to the boosted inflammation and apoptosis, heightened DA levels in the cortex parallel\n",
      "along with increased tyrosine hydroxylase in midbrain were apparent. Concomitant administration of tramadol\n",
      "and nicotine impaired spatial navigation in the Morris Water Maze test coupled with enhanced levels of acetyl-\n",
      "and butyryl cholinestrases. However, tramadol in association with nicotine improved social interaction while\n",
      "decreasing anxiety and aggression linked to chronic administration of nicotine, effects manifested by increased\n",
      "levels of serotonin and GABA. These results provide evidence that co-administration of tramadol and nicotine\n",
      "may enhance reward and dependence while reducing anxiety and aggression linked to nicotine administration.\n",
      "However, such combination exacerbated neurotoxic effects and elicited negative effects regarding learning and\n",
      "memory.\n",
      "\n",
      "1. Introduction\n",
      "\n",
      "Drug addiction, including polydrug use, can be defined as a mala-\n",
      "daptive behavior which is characterized by “loss of control \"over drug\n",
      "use (Balconi et al., 2014). The diversity and abuse of prescription drugs,\n",
      "particularly opioids is a major worldwide tendency (Simonsen et al.,\n",
      "2015). Nonetheless, concomitant drug dependence is not only limited\n",
      "to prescription medications but also encompasses nicotine and opioids.\n",
      "In this context, some epidemiological studies revealed that tobacco\n",
      "smoking and illicit drug use are frequently a co-occurring behavior\n",
      "\n",
      "(Frosch et al., 2000; Elkader et al., 2009; Epstein et al., 2010).\n",
      "Tramadol, a centrally acting synthetic opioid, that possesses anti-\n",
      "\n",
      "nociceptive and analgesic effects (Raffa, 2008) has emerged rapidly as a\n",
      "drug of abuse in the past few years (Shalaby et al., 2015). It has been\n",
      "postulated that the pharmacological effects of tramadol may be medi-\n",
      "ated by both opioid (μ-receptor agonist) and non-opioid (nor-\n",
      "epinephrine and serotonin reuptake inhibition) mechanisms (Raffa\n",
      "et al., 1992; Liu et al., 1999; Nossaman et al., 2010), with the in-\n",
      "volvement of both in development of drug addiction (Zhuo et al., 2012).\n",
      "Noteworthy, tramadol metabolite, o-desmethyl tramadol (M1), is also\n",
      "\n",
      "https://doi.org/10.1016/j.neuro.2018.06.004\n",
      "Received 12 December 2017; Received in revised form 16 May 2018; Accepted 10 June 2018\n",
      "\n",
      "⁎ Corresponding author.\n",
      "E-mail address: noha.nassar@pharma.cu.edu.eg (N.N. Nassar).\n",
      "\n",
      "Abbreviations: AChE, acetylcholinesterase; BuChE, butyrylcholinesterase; GABA, gamma aminobutyric acid; GLU, Glutamate; GSH, reduced glutathione; iNOS, Inducible nitric oxide\n",
      "synthase; LLE, liquid liquid extraction; M1, O-desmethyl tramadol; MWM, morris water maze; NFκB, nuclear factor kappa B; NMDA, n-methyl-D-aspartate; nNOS, neuronal nitric oxide\n",
      "synthase; NO, nitric oxide; NOS, nitric oxide synthase; NPSH, non protein sulfhydryl; OFT, open field test; RNS, reactive nitrosative species; ROS, reactive oxygen species; SI, social\n",
      "interaction; TBARS, thiobarbituric acid reactive substances; TH, tyrosine hydroxylase; TNF-α, tumor necrosis factor alpha; VTA, ventral tegmental area\n",
      "\n",
      "Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "Available online 12 June 2018\n",
      "0161-813X/ © 2018 Elsevier B.V. All rights reserved.\n",
      "\n",
      "T\n",
      "\n",
      "http://www.sciencedirect.com/science/journal/0161813X\n",
      "https://www.elsevier.com/locate/neuro\n",
      "https://doi.org/10.1016/j.neuro.2018.06.004\n",
      "https://doi.org/10.1016/j.neuro.2018.06.004\n",
      "mailto:noha.nassar@pharma.cu.edu.eg\n",
      "https://doi.org/10.1016/j.neuro.2018.06.004\n",
      "http://crossmark.crossref.org/dialog/?doi=10.1016/j.neuro.2018.06.004&domain=pdf\n",
      "\n",
      "\n",
      "active as μ-receptor agonist, such that the long-term use of tramadol can\n",
      "induce tolerance, physical dependence and withdrawal symptoms\n",
      "(Abdel-Zaher et al., 2011). Addicts may revert to tramadol combina-\n",
      "tions with other substances of abuse either to increase euphoria,\n",
      "achieve more favorable effects, act as a substitute or avoid/relieve the\n",
      "opioid-related withdrawal symptoms (Gibson, 1996; Liu et al., 1999);\n",
      "however, these practices have augmented the number of deaths in re-\n",
      "cent years (Sheikholeslami et al., 2016).\n",
      "\n",
      "Tobacco consumption is one of the main public health problems\n",
      "worldwide and represents a leading cause of preventable deaths in most\n",
      "developed countries (Dwoskin et al., 2009; Berrendero et al., 2010).\n",
      "Nicotine, the reinforcing addictive component of tobacco, is the major\n",
      "arbitrator that maintains the smoking habit (Shoaib, 2006). Like other\n",
      "addictive drugs, nicotine displays the two important characteristics to\n",
      "establishing and maintaining addiction; first, by eliciting pleasant or\n",
      "rewarding effects in the brain which reinforce self-administration be-\n",
      "havior; and secondly, appearance of withdrawal syndrome following\n",
      "chronic exposure to nicotine which favors continued intake (Lewis\n",
      "et al., 2007).\n",
      "\n",
      "Neurochemical studies revealed that nicotine and opioids modulate\n",
      "each other effect (Skurtveit et al., 2010) and nicotine induced DA re-\n",
      "lease via activation of μ opioid receptors (Tanda and Di Chiara, 1998).\n",
      "Moreover, experimental studies highlighted the existence for a me-\n",
      "chanistic overlap between opiates and nicotine within dopamine (DA)\n",
      "reward pathway (Britt and McGehee, 2008; Berrendero et al., 2010). In\n",
      "light of these considerations, the aim of this work was to investigate the\n",
      "possible modulatory effects of nicotine on tramadol-induced neurobe-\n",
      "havioral and neuropathological changes in the brain. In addition, an\n",
      "attempt was undertaken to clarify the possible neurochemical altera-\n",
      "tions in neurotransmitters, inflammation and oxidative/nitrosative\n",
      "stress.\n",
      "\n",
      "2. Material and methods\n",
      "\n",
      "2.1. Animals\n",
      "\n",
      "Adult male Swiss albino mice weighing 25–30 g were purchased\n",
      "from the animal house colony of the national research center (NRC,\n",
      "Giza, Egypt). Mice were allowed one week acclimatization period and\n",
      "were housed in groups at constant temperature (23 ± 2 °C), humidity\n",
      "(60 ± 10%) and a light/dark (12/12 h) cycle with lights on at 5:00 am.\n",
      "They were allowed free access to food and water throughout the ex-\n",
      "perimental period. All behavioral experiments were carried out in se-\n",
      "parate and isolated laboratories. The study was performed in com-\n",
      "pliance with the procedures and policies approved by the Research\n",
      "Ethics Committee of Faculty of Pharmacy, Cairo University (Cairo,\n",
      "Egypt; PT 1452) in compliance with the Guide for the Care and Use of\n",
      "Laboratory Animals (ILAR, 1996).\n",
      "\n",
      "2.2. Drugs and chemicals\n",
      "\n",
      "Tramadol hydrochloride was obtained from Memphis Company\n",
      "(Cairo, Egypt); nicotine solution was purchased from Sigma-Aldrich\n",
      "(MO, USA). All other chemicals and reagents used for biochemical es-\n",
      "timations were of analytical grade.\n",
      "\n",
      "2.3. Drug treatment schedule\n",
      "\n",
      "Mice were divided in to 4 groups and treated as follows: (i) group I\n",
      "served as control and received the vehicle; (ii) animals in group II were\n",
      "given tramadol (20mg / kg, i.p); (iii) group III received nicotine\n",
      "(0.25 mg/kg, i.p); and (iv) group IV was given tramadol and nicotine at\n",
      "the same doses mentioned earlier. All agents were dissolved in saline\n",
      "and administrated once daily for thirty days. All animals were subjected\n",
      "to behavioral experiments that were performed at the same time-period\n",
      "of the day (09:00 am -12:00 pm). Behavioral tests were carried out\n",
      "\n",
      "throughout the last week of the experiment while body weight was\n",
      "taken on weekly basis. Following the exclusion of dead animals in each\n",
      "group, the experimental groups I and III consisted of (6–8 animals)\n",
      "whereas groups II and IV included (12–14 animals). Thirty minutes\n",
      "following last tramadol injection in groups II and IV, (4–6 mice) were\n",
      "euthanized and the brains were isolated for detection of tramadol in\n",
      "brain. Twenty-four hours following the last treatment, (6–8 mice each\n",
      "group) were euthanized with cervical dislocation and brains were iso-\n",
      "lated. Cortices were dissected over ice for neurotransmitters and bio-\n",
      "chemical analysis. Part of cortical tissue was homogenized in 75%\n",
      "methanol (HPLC grade, Sigma-Aldrich) and cortical monoamines were\n",
      "measured. Derivatization of dried cortical homogenate was carried out\n",
      "for determination of GABA and glutamate. The rest of cortical tissue\n",
      "was homogenized in phosphate buffer saline (pH 7.4) for estimation of\n",
      "other mediators in cortices. Samples were stored at −80 °C till analysis.\n",
      "\n",
      "2.4. Detection of tramadol in brain\n",
      "\n",
      "Thirty minutes following the last injection, mice were euthanized\n",
      "with cervical dislocation and brains were isolated and homogenized in\n",
      "Tris−HCl buffer. Extraction of tramadol from brain homogenates was\n",
      "performed according to the method described by Tao et al. (2001).\n",
      "Briefly, methanol was used for protein precipitation and methyl tertiary\n",
      "butyl ether (MTBE) was utilized for liquid-liquid extraction (LLE).\n",
      "Subsequently, the MTBE layer was evaporated under nitrogen flow and\n",
      "the residue was reconstituted with 50 μl of methanol (HPLC grade). A\n",
      "sample volume of 3 μl was injected in GC.MS (Agilent 6890 Network\n",
      "capillary gas chromatograph equipped with a mass selective detector\n",
      "Agilent 5973 Network; CA, USA) using dextromethorphan as internal\n",
      "standard (I.S.).\n",
      "\n",
      "2.5. Biochemical measurements\n",
      "\n",
      "2.5.1. Determination of cortical TBARS, NPSHs and NO contents\n",
      "Thiobarbituric acid reactive substances (TBARS) content was mea-\n",
      "\n",
      "sured according to the method described by Mihara and Uchiyama\n",
      "(1978). In brief, thiobarbituric acid in o-phosphoric acid was added to\n",
      "the homogenate and boiled for 20min, cooled and centrifuged at 1000 g\n",
      "for 10min then the resultant complex was read at 532 nm. Non protein\n",
      "sulfhydryls (NPSHs) content was measured according to the method of\n",
      "Ellman (1959) and modified by Beutler et al. (1963). After precipitation\n",
      "of protein, Ellman’s reagent (5, 5\\-dithiobis-2-nitrobenzoic acid) was\n",
      "reduced by sulfhydryl (SH) group to form 2-nitro-5-mercaptobenzoic\n",
      "acid that has an intense yellow color and can be determined color-\n",
      "imetrically at 412 nm. Nitric oxide (NO) was determined using Griess\n",
      "reagent according to the method described by Miranda et al. (2001), the\n",
      "absorbance was read at 540 nm.\n",
      "\n",
      "2.5.2. Determination of cortical TNF-α, NFκB, iNOS and nNOS\n",
      "ELISA kits for tumor necrosis factor α (TNF-α; CSB-E04741), nu-\n",
      "\n",
      "clear factor kappa B (NFκB; CSB-E12108) and inducible nitric oxide\n",
      "synthase (iNOS; CSB-E08326) were purchased from Cusabio (Wuhan,\n",
      "PRC) whereas neuronal nitric oxide synthase (nNOS; MBS753956) was\n",
      "obtained from MyBioSource (CA, USA) and used according to the\n",
      "manufacturers’ instructions.\n",
      "\n",
      "2.5.3. Determination of cortical monoamines and amino acids\n",
      "Estimation of dopamine (DA), serotonin (5 H T) and norepinephrine\n",
      "\n",
      "(NE) was carried out according to the method of Pagel et al. (2000)\n",
      "using HPLC (Perkin-Elmer, MA, USA). Briefly, homogenized samples\n",
      "were extracted from trace elements and lipids by solid phase extraction.\n",
      "Each sample (40 μl) was filtered (0.25 μm, Millipore, MA, USA) then\n",
      "injected into an AQUA column (C18, 150× 4.6mm, 5 μm, Phenom-\n",
      "enex,CA, USA), using mobile phase (methanol: acetonitrile; 97:3 v),\n",
      "flow rate 1.5 ml/min, and peaks were detected at 270 nm. Moreover,\n",
      "glutamate (GLU) and gamma amino butyric acid (GABA) were\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "246\n",
      "\n",
      "\n",
      "\n",
      "estimated according to the method of Heinrikson and Meredith (1984),\n",
      "using the HPLC system (Perkin-Elmer). The reconstituted cortical re-\n",
      "sidues (methanol: 1M sodium acetate: triethylamine; 2:2:1 v) were re-\n",
      "dried under vacuum. Using the precolumn isothiocyanate derivatiza-\n",
      "tion technique, samples were subjected to a 20min derivatization\n",
      "performed using a methanol: triethylamine: double-distilled deionized\n",
      "water: phenylisothiocyanate (7:1:1:1 v), redried under vacuum, then\n",
      "reconstituted with sample diluents (acetonitrile: 5 mM phosphate\n",
      "buffer; 5:95 v; pH=7.2). Sonicated and filtered (0.45 μm; Millipore)\n",
      "samples were run on a Pico-Tag C18 (300mm×3.9mm, i.d., Waters,\n",
      "CT, USA) and a binary gradient of Eluents 1 and 2 (Waters) were used.\n",
      "Column temperature (46 ± 1 °C) and a constant flow rate (1 ml/min)\n",
      "were sustained throughout the experiment. A sample volume of 20 μl\n",
      "was injected and the corresponding peaks were detected at 254 nm.\n",
      "\n",
      "2.5.4. Determination of cortical acetyl- / butyrylchloinestrases\n",
      "The procedure used for acetylcholinesterase (AChE) was a mod-\n",
      "\n",
      "ification of the method of Ellman et al. (1961) as described by Gorun\n",
      "et al. (1978). The principle of the method is the measurement of the\n",
      "thiocholine produced as acetylthiocholine is hydrolyzed. The color was\n",
      "read immediately at 412 nm. Butrylcholinesterase (BuChE) activity in\n",
      "cortical supernatant was determined using butrylcholinesterase diag-\n",
      "nostic kit purchased from Biodiagnostic (Cairo, Egypt) according to the\n",
      "method of Knedel and Bottger (1967).\n",
      "\n",
      "2.6. Behavioral tests\n",
      "\n",
      "2.6.1. Open field test (OFT)\n",
      "The open field test was performed according to the method de-\n",
      "\n",
      "scribed by Bailey and Crawley (2009). The OF is a square wooden arena\n",
      "(40 cm x 40 cm x 20 cm high) with red walls and white smooth polished\n",
      "floor that is divided into a grid of equally sized areas by lines drawn on\n",
      "the chamber floor for visual scoring of activity by the experimenter. The\n",
      "following parameters were recorded during the 5min observation\n",
      "period: (i) thigmotaxis time (time spent by the animal exploring the\n",
      "periphery of the arena, usually in contact with the walls and corners);\n",
      "(ii) central square frequency: (frequency with which the mice crossed\n",
      "with all four paws into the central square area); (iii) ambulation fre-\n",
      "quency: number of squares crossed by the animal; (iv) rearing fre-\n",
      "quency: number of times the animal stood stretched on its hind limbs\n",
      "with or without forelimb support and (v)grooming frequency: number\n",
      "of face scratching, washing with the hind limbs and licking of the\n",
      "forelimbs.\n",
      "\n",
      "2.6.2. Social interaction test (SI)\n",
      "Test was performed according to the method described by Niijima-\n",
      "\n",
      "Yaoita et al. (2013). The apparatus for the SI test was made of a clear\n",
      "polycarbonate (25.7 cm x 30.8 cm x 18.0 cm high). After habituation for\n",
      "30min, the mouse to be tested was randomly assigned to an unfamiliar\n",
      "partner (visitor mouse) of the same strain, age and sex. The pair of\n",
      "unfamiliar mice was placed in the apparatus for 10min and the total\n",
      "amount of time spent in active SI, such as sniffing, grooming, following\n",
      "and mounting as well as crawling over or under the visitor mouse in\n",
      "direct contact was recorded.\n",
      "\n",
      "2.6.3. Defensive aggression test\n",
      "Test was performed according to the method described by\n",
      "\n",
      "Johansson et al. (2000). For the defensive aggression test, the mouse\n",
      "was lifted by its tail and placed in a Plexiglas cage (60×31×41 cm\n",
      "high) and allowed to habituate for 30 s. The reaction of each mouse to\n",
      "four different stimuli was then assessed. (i) A wooden rod was slowly\n",
      "moved to approach and touch the mouse′s snout (0: no response or\n",
      "sniffs at the rod; 1: intermittently bites or attacks the rod and/or adopts\n",
      "a defensive upright posture; 2: continuously bites/attacks the rod). (ii)\n",
      "Startle to an air puff (air blown from a 50-ml syringe) at the back (0: no\n",
      "response or some movement; 1: jumping response; 2: exaggerated\n",
      "\n",
      "jumping response). (iii) Poking with wooden rod at the flanks (0: no\n",
      "response or sniffing at the rod; 1: defensive upright posture; 2: defen-\n",
      "sive upright posture together with biting/attack). (iv) Capturing with a\n",
      "gloved hand (0: very easy to capture; 1: easy to capture but some re-\n",
      "sistance and/or prolonged vocalization; 2: difficult to capture because\n",
      "of escape; 3: difficult to capture because of attacking or biting; 4: very\n",
      "difficult to capture because of continuous violent attacks/bites). The\n",
      "averages of the total scores (maximum total score 10) from each in-\n",
      "dividual stimuli test was used in the statistical calculations.\n",
      "\n",
      "2.6.4. Morris Water Maze test (MWM)\n",
      "Trail Test: Individual animals were tested in a spatial version of\n",
      "\n",
      "Morris Water Maze test according to the method described by Bromley-\n",
      "Brits et al. (2011). The maze consists of a large circular pool with a\n",
      "diameter of 150 cm and a depth of 50 cm of water maintained at room\n",
      "temperature. A platform (10 cm diameter) was located in the pool and\n",
      "concealed below the surface of the water (i.e., ∼ 1 cm). The platform\n",
      "was rendered invisible by making the water opaque using powdered\n",
      "milk. The water maze task was carried out in the last week of the ex-\n",
      "periment. Mice received five consecutive daily training trials in the\n",
      "following 5 days, with each trial exhibiting a cut-off time of 60 s and a\n",
      "trial interval of approximately 30 s. If the mouse failed to reach the\n",
      "escape platform within the maximally allowed time of 60 s, it was\n",
      "guided with the help of the experimenter and allowed to remain on the\n",
      "platform for 20 s. The time to reach the platform (escape latency in\n",
      "seconds) was measured.\n",
      "\n",
      "Memory consolidation test (probe trial): The time spent in the\n",
      "target quadrant indicates the degree of memory consolidation that has\n",
      "taken place after learning. In the probe trial, the mouse was placed into\n",
      "the pool as in the training trial, except that the hidden platform was\n",
      "removed from the pool. The total time spent in target quadrant in a\n",
      "period of 60 s was recorded (Bromley-Brits et al., 2011).\n",
      "\n",
      "2.7. Histopathological examination\n",
      "\n",
      "The brain of each mouse was carefully dissected out and fixed in\n",
      "10% buffered neutral formalin. The fixed brain specimens were routi-\n",
      "nely dehydrated by graded series of alcohol, cleared in xylol and finally\n",
      "embedded in paraffin. Paraffin blocks were serially sectioned at 4 um\n",
      "thickness and stained with haematoxylin and eosin stains (H&E)\n",
      "(Bancroft and Gamble, 2008). The obtained sections were collected on\n",
      "glass slides, and subjected to histopathological examination using the\n",
      "electric light microscope Olympus BH2 (Tokyo, Japan).\n",
      "\n",
      "2.8. Immunohistocemical examination of CD68, Casp-3 and TH\n",
      "\n",
      "For recognition of CD68, caspase-(Casp)-3 and tyrosine hydroxylase\n",
      "(TH) reactive cells, immunohistochemical procedures were carried out\n",
      "on 4 μm paraffin sections of brain tissue of control and different treated\n",
      "groups using avidin-biotin peroxidase according to the method de-\n",
      "scribed by Hsu et al. (1981). Briefly, paraffin sections were depar-\n",
      "affinized in toluene, rehydrated in ethanol, and then incubated with\n",
      "H2O2 for blocking the endogenous peroxidase activity. The sections\n",
      "were incubated with a monoclonal antibody for CD68, casp-3 and TH\n",
      "(Dako Corp, CA, USA). The immune reactive cells for each marker were\n",
      "visualized using the chromagen 3, 3-diaminobenzidine tetra-\n",
      "hydrochloride (DAB, Sigma-Aldrich, MO, USA). The number of apop-\n",
      "totic cells (Casp-3 dependent) was determined by counting the number\n",
      "of positive cells in 5 randomly chosen microscopic fields at 40x objec-\n",
      "tive magnification, the area for each microscopic field is 18.8913Sqmm.\n",
      "\n",
      "2.9. Statistical analysis\n",
      "\n",
      "All values are presented as means ± standard deviation of the\n",
      "means (SD). Comparison between groups was carried out using the non-\n",
      "parametric one-way analysis of variance (ANOVA) followed by Tukey-\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "247\n",
      "\n",
      "\n",
      "\n",
      "Kramer Multiple Comparison Test for all the parameters. For the body\n",
      "weight change and MWM, two-way analysis of variance (ANOVA) fol-\n",
      "lowed by Bonferroni Multiple Comparison Test was used. Difference\n",
      "was considered significant when P<0.05. Survival analysis was car-\n",
      "ried out using Kaplan-Meier plots and log rank (Mantel-Cox) tests.\n",
      "Graphpad Prism® 5.00 for Windows Software (CA, USA) was used to\n",
      "carry out these statistical tests and graphical presentation.\n",
      "\n",
      "3. Results\n",
      "\n",
      "3.1. Survival analysis and body weight change\n",
      "\n",
      "Unlike the control group that displayed 100% survival, groups in\n",
      "the tramadol, nicotine or their combination groups showed progressive\n",
      "decline in survival. Tramadol alone had significantly higher survival\n",
      "compared to group receiving tramadol and nicotine (95% vs 60% sur-\n",
      "vival; p= 0.0068). In addition, simultaneous administration of nicotine\n",
      "with tramadol significantly lowered survival compared to nicotine per\n",
      "se (60% vs 90% survival; p= 0.0286). No significant change in survival\n",
      "was observed between tramadol and nicotine groups (Fig. 1a).\n",
      "\n",
      "Injection of tramadol (20mg/kg; i.p.) produced a significant de-\n",
      "crease in body weight (BW) starting the 2nd week and through the end\n",
      "of the 4th week of drug administration compared to control (Fig. 1b). By\n",
      "the same token, nicotine induced a noticeable decline starting from the\n",
      "\n",
      "1st week compared to normal control mice, which by the end of the 4th\n",
      "\n",
      "week, showed a significant decrease (13.7%) compared to their control\n",
      "counterparts (Fig. 1b). As illustrated in (Fig. 1b), at the end of 4th week\n",
      "there was a significant drop in body weight by 18.5 and 12% compared\n",
      "to control and tramadol, respectively with nicotine and tramadol co-\n",
      "administration.\n",
      "\n",
      "3.2. Changes in tramadol concentration in mice brain induced by\n",
      "concomitant administration of nicotine with tramadol\n",
      "\n",
      "Tramadol (20mg/kg, i.p) was rapidly absorbed with a concentra-\n",
      "tion mounting to 0.71 μg/g in the brain after 30min (Fig. 2a). A sig-\n",
      "nificant boost in tramadol concentration was observed with the co-\n",
      "administration of nicotine (0.25 mg/kg, i.p) and tramadol produced\n",
      "reaching 91%, compared to tramadol group (Fig. 2a, b).\n",
      "\n",
      "3.3. Alterations in CD68 immunoreactivity induced by tramadol, nicotine\n",
      "and their combined administration\n",
      "\n",
      "CD68 immunoreactivity showed distinctive rod-like morphology of\n",
      "microglia in the examined cerebral cortices of control and all treated\n",
      "groups. The cerebral cortices of control mice revealed appearance of\n",
      "few scattered immunorective CD68 microglia (Fig. 3a); while both\n",
      "tramadol and nicotine administration showed increased im-\n",
      "munoreactive microglia cells (Fig. 3b-c). The combined administration\n",
      "of tramadol and nicotine resulted in more activation of microgila cells\n",
      "denoted by marked increased expression of CD68 (Fig. 3d).\n",
      "\n",
      "Fig. 1. (a): Kaplan-Meier survival curve (N=20) showing higher survival with\n",
      "tramadol and nicotin alone compared to the group receiving both drugs. No\n",
      "significant change in survival was observed between tramadol and nicotine\n",
      "groups. P-values were calculated with log-rank (Mantel-Cox) test. (b):\n",
      "Tramadol administration induced a significant decrease in BW from the 2nd\n",
      "\n",
      "week of the test. Mice subjected to nicotine either alone or in combination with\n",
      "tramadol showed a significant decrease in BW from the 1st week of the ex-\n",
      "periment. Data are expressed as mean of (8) experiments ± SD. Statistical\n",
      "analysis were carried out by two way ANOVA followed by Bonferroni post test.\n",
      "*: significant from control, #: significant from tramadol, @: significant from\n",
      "nicotine at p < 0.05.\n",
      "\n",
      "Fig. 2. (a): Representative chromatogram of an extract of a brain sample col-\n",
      "lected from a mouse receiving (20mg/kg) of tramadol 30min prior to sample\n",
      "collection. (b): Animals receiving tramadol+ nicotine displayed an increment\n",
      "in tramadol concentration in the brain versus those receiving tramadol alone.\n",
      "Data are expressed as mean of (4–6) experiments ± SD. Statistical analyses\n",
      "were carried out by ANOVA followed by Tukey’s Multiple Comparison Test. *:\n",
      "significant from tramadol at P < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "248\n",
      "\n",
      "\n",
      "\n",
      "3.4. Effect of nicotine on tramadol-induced alterations in cortical TBARS,\n",
      "NPSHs and NO contents in mice\n",
      "\n",
      "Tramadol and nicotine given alone produced a buildup in TBARS\n",
      "(46.5 and 63.%, respectively) and NO contents by (1.4 and 1.2 fold,\n",
      "respectively) accompanied by a decline NPSHs (20 and 30%, respec-\n",
      "tively) compared to control group (Fig. 4a-c). By the same token, ni-\n",
      "cotine given concurrently with tramadol elevated TBARS and NO levels\n",
      "by 76.8 and 180%, respectively, paralleled with a reduction in NPSHs\n",
      "level by 31.5% compared to control group. Interestingly, the increase in\n",
      "TBARS and NO was significant compared to each drug alone (Fig. 4a-c).\n",
      "\n",
      "3.5. Changes in nNOS and iNOS induced by tramadol either alone or in\n",
      "combination with nicotine\n",
      "\n",
      "Tramadol as well as nicotine elevated nNOS (2.1 and 3.1 folds, re-\n",
      "spectively) as well as iNOS (2.1 and 6.3 fold, respectively) in cerebral\n",
      "cortex compared to control (Fig. 5c-d). On the other hand, adminis-\n",
      "tration of nicotine concurrently with tramadol augmented the elevation\n",
      "in concentrations of nNOS (4.3 fold) and iNOS (8.2 fold) compared to\n",
      "control group (Fig. 5c-d), with values significantly greater when com-\n",
      "pared to either tramadol or nicotine groups.\n",
      "\n",
      "3.6. Effect of nicotine on tramadol – induced alterations in cortical NFκB,\n",
      "TNF-α as well as Casp-3 immunoreactivity\n",
      "\n",
      "The transcription factor (NFκB) and its downstream proin-\n",
      "flammatory cytokine (TNF-α) were raised by the single administration\n",
      "of tramadol (1 fold, each) or nicotine (3.2 and 2.3 folds respectively) in\n",
      "cerebral cortex compared to their control counterparts (Fig. 5a–b). The\n",
      "step-up in NFκB and TNF-α levels induced by nicotine was remarkable\n",
      "compared to tramadol group (Fig. 5a–b).Furthermore, co-administra-\n",
      "tion of nicotine with tramadol induced significant increases in NFκB\n",
      "and TNF-α compared to tramadol and nicotine groups (Fig. 5a–b).\n",
      "Additionally, control mice showed negative expression of Casp-3 in\n",
      "cerebral cortex (Fig. 6a). Conversely, both tramadol and nicotine alone\n",
      "or in combination showed Casp-3 immunoreactive positive cells de-\n",
      "picted by the intense brown staining (Figs. 6b-e). The number of\n",
      "\n",
      "apoptotic cells (Casp-3 dependent) was determined by counting the\n",
      "number of positive cells in 5 randomly chosen microscopic fields at 40 x\n",
      "objective magnification (Fig.6f).\n",
      "\n",
      "3.7. Changes in cortical DA level as well as midbrain TH immunoreactitvity\n",
      "induced by tramadol either alone or in combination with nicotine\n",
      "\n",
      "Following 24 h of the last injection, DA was significantly elevated in\n",
      "cerebral cortex of mice subjected to tramadol or nicotine by 65 and\n",
      "33.6%, respectively compared to control group (Table 1). Moreover,\n",
      "mice given tramadol on top of nicotine showed increased DA level by\n",
      "61 and 20.4%, respectively in cerebral cortex compared to control and\n",
      "nicotine groups. Nonetheless, the increase in DA level showed no sig-\n",
      "nificance compared to tramadol group (Table 1). Furthermore, control\n",
      "group showed minimal immunostaining for TH (Fig. 7a). Both of tra-\n",
      "madol and nicotine alone or in combination induced more TH im-\n",
      "munoreactive cells (Figs. 7b-d).\n",
      "\n",
      "3.8. Changes in cortical 5 H T and NE levels induced by tramadol either\n",
      "alone or in combination with nicotine\n",
      "\n",
      "Mice treated with tramadol and nicotine showed a buildup in cor-\n",
      "tical NE (20.8 and 43.7%, respectively), however only those receiving\n",
      "tramadol displayed an increment in cortical 5 H T level (66.6%) com-\n",
      "pared to their control counterparts (Table 1). In addition, co-adminis-\n",
      "tration of nicotine concurrently with tramadol increased 5 H T by 44\n",
      "and 25.6% compared to nicotine and control groups, respectively.\n",
      "Furthermore, mice given tramadol and nicotine displayed a significant\n",
      "increase in NE level (16.6%) compared to control group (Table 1).\n",
      "\n",
      "3.9. Changes in cortical glutamate and GABA levels induced by tramadol\n",
      "either alone or in combination with nicotine\n",
      "\n",
      "Single administration of tramadol as well as nicotine elevated cor-\n",
      "tical glutamate by 24.3 and 29.3% compared to their control counter-\n",
      "parts (Table 1). Conversely, only tramadol induced an increment in\n",
      "GABA (69.3%), the latter being reduced by nicotine (23%) compared to\n",
      "control group (Table 1). Furthermore, the increase in glutamate level\n",
      "\n",
      "Fig. 3. Photomicrograph depicting CD68 immunohistochemical staining in the cerebral cortex. Brown color (positive) indicates specific immunostaining for CD68.\n",
      "Control mice showing few scattered CD68 immunopositive microglia cells (a). Increased immunoreactivity of CD68 among activated microglia cells after tramadol\n",
      "and nicotine administration (b and c). Marked increased activation of microglia expressing CD68 in mice subjected to tramadol and nicotine (d). Quantitative image\n",
      "analysis for immunohistochemical staining expressed as optical densities (OD) across 10 different fields for each mouse section (e).\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "249\n",
      "\n",
      "\n",
      "\n",
      "(79.8%) induced by the co-administration of tramadol and nicotine was\n",
      "significant compared to control, as well as to that produced by tramadol\n",
      "or nicotine alone. Meanwhile, there was a significant increase in GABA\n",
      "level compared to control and nicotine groups (Table 1).\n",
      "\n",
      "3.10. Effect of tramadol either alone or in combination with nicotine on\n",
      "acetyl- and butyrylcholinestrases in cerebral cortex\n",
      "\n",
      "Mice treated with tramadol showed no change in acetyl cholines-\n",
      "terase concentration and butyrylcholinestrase activity in cerebral cortex\n",
      "(Fig. 8a–b). Nicotine produced a significant increase in cortical acet-\n",
      "ylcholinestrase by 51.2 and 35.4% compared to control and tramadol\n",
      "groups, respectively. However, nicotine had no effect on butyr-\n",
      "ylcholinestrase activity (Fig. 8a–b). Furthermore, nicotine admini-\n",
      "strated concurrently with tramadol induced elevation in acet-\n",
      "ylcholinesterase concentration and butyrylcholinestrase activity\n",
      "compared to control and tramadol groups (Fig. 8a–b). However, this\n",
      "increase was not significant compared to nicotine group.\n",
      "\n",
      "3.11. Alterations in spatial memory in the Morris Water Maze test\n",
      "consequent to tramadol administration either alone or in combination with\n",
      "nicotine\n",
      "\n",
      "The escape latencies to reach hidden platform decreased gradually\n",
      "in control group, indicating good learning performance (Fig. 9a). In\n",
      "opposition, mice subjected to tramadol and nicotine either alone or in\n",
      "combination showed a disturbed performance in MWM with different\n",
      "extents, with tramadol showing the least disturbed performance\n",
      "(Fig. 9a). The escape latency was significantly increased in case of ni-\n",
      "cotine treated mice compared to tramadol and control groups, in-\n",
      "dicating a poor learning performance, an effect that was accentuated by\n",
      "co-administration of tramadol with nicotine, showing a poorer learning\n",
      "performance (Fig. 9a). In the probe trial, the time spent in the target\n",
      "quadrant was significantly lowered in tramadol and nicotine as well as\n",
      "tramadol/nicotine groups compared to control group (Fig. 9b) sug-\n",
      "gesting poor memory consolidation.\n",
      "\n",
      "3.12. Influence of co-administration of nicotine with tramadol on aggressive\n",
      "behavior\n",
      "\n",
      "Mice given tramadol showed no change in aggression scores\n",
      "\n",
      "Fig. 4. Mice given tramadol or nicotine in addition to tramadol showed increased TBARS (a) lowered NPSH (b) in addition to elevated nitric oxide (c) levels. Data are\n",
      "expressed as mean of (6–8) experiments ± SD. Statistical analyses were carried out by ANOVA followed by Tukey’s Multiple Comparison Test. *: significant from\n",
      "control, #: significant from tramadol at P < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "250\n",
      "\n",
      "\n",
      "\n",
      "compared to their control counterparts (Fig. 9c), while those receiving\n",
      "nicotine displayed a prominent aggression score (7.3 fold) compared to\n",
      "control (Fig. 9c). However, mice given tramadol together with nicotine\n",
      "showed a decline in aggression score compared to nicotine group\n",
      "(Fig. 9c).\n",
      "\n",
      "3.13. Impact of co-administration of nicotine with tramadol on social\n",
      "interaction test\n",
      "\n",
      "Mice treated with tramadol showed no change in social interaction\n",
      "time compared to their control counterparts (Fig. 9d), on the other\n",
      "hand, nicotine decreased SI time by 53.8% compared to control group\n",
      "(Fig. 9d). Interestingly, mice treated with tramadol and nicotine\n",
      "showed a significant increase in SI time by 49.8% compared to nicotine\n",
      "group (Fig. 9d).\n",
      "\n",
      "3.14. Effect of tramadol either alone or in combination with nicotine on\n",
      "assessment of anxiety-related behavior in OFT\n",
      "\n",
      "3.14.1. Thigmotaxis time and central square frequency\n",
      "Mice receiving tramadol produced a significant increase in central\n",
      "\n",
      "square entry frequency (2.4 fold) paralleled by a significant decrease in\n",
      "thigmotaxis time (40.7%) compared to control, indicating anxiolytic\n",
      "effect of tramadol (Fig. 10a–b). On the contrary, animals that were\n",
      "given nicotine exhibited anxiogenic performance which was reflected\n",
      "\n",
      "by no change in thigmotaxis time or central square entry frequency\n",
      "compared to control group (Fig. 10 a–b). Notably, mice receiving ni-\n",
      "cotine with tramadol showed a significant decrease in thigmotaxis time\n",
      "accompanied with a significant increase in central square frequency\n",
      "compared to nicotine group (Fig. 10 a–b).\n",
      "\n",
      "3.14.2. Ambulation and rearing frequencies\n",
      "Injection of tramadol produced a significant increase in ambulation\n",
      "\n",
      "and rearing frequencies by 32 and 67%, respectively, compared to\n",
      "control (Fig. 10c-d). Mice given nicotine showed no significant change\n",
      "in ambulation and rearing frequencies compared to their control\n",
      "counterparts. Similarly, co-administration of tramadol with nicotine\n",
      "resulted in insignificant change in ambulation and rearing frequencies\n",
      "compared to control group (Fig. 10c-d).\n",
      "\n",
      "3.14.3. Grooming frequency\n",
      "Both tramadol and nicotine alone or in combination produced sig-\n",
      "\n",
      "nificant increases in grooming frequency compared to control group\n",
      "(Fig. 10e).\n",
      "\n",
      "3.15. Histopathological changes in cortices of mice subject to tramadol\n",
      "alone or in combination with nicotine\n",
      "\n",
      "The brain sections of control mice showed normal histological\n",
      "structure (Fig. 11A/a). Generally it was noticed that nicotine\n",
      "\n",
      "Fig. 5. Mice subjected to tramadol either alone or in combination with nicotine showed increment in cortical levels of NFκB (a), TNF-α (b), nNOS (c) and iNOS (d).\n",
      "Data are expressed as mean of (6–8) experiments ± SD. Statistical analyses were carried out by ANOVA followed by Tukey’s Multiple Comparison Test. *: significant\n",
      "from control, #: significant from tramadol, @: significant from nicotine at p < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "251\n",
      "\n",
      "\n",
      "\n",
      "administration had more adverse effect than that caused by tramadol.\n",
      "Additionally, the combined administration had more deleterious effect\n",
      "than the sole administrations. The between-group comparisons were\n",
      "made in the same anatomic layers of the cerebral cortex (mostly layers\n",
      "II to V were the most affected with less severity in layers I and VI).\n",
      "\n",
      "The brain sections of mice given tramadol (Fig. 11A/b) showed\n",
      "vacuolar degeneration and necrosis of some pyramidal neurons\n",
      "(Fig. 11A/c) with neuronophagia, the necrotic cells appeared darkly\n",
      "stained, structure-less without nuclei while others appeared faintly\n",
      "stained ghost–like. Apoptotic cells and few apoptotic bodies were no-\n",
      "ticed (Fig. 11A/d) with some dilated and congested blood capillaries.\n",
      "The brain of mice subjected to nicotine (Fig. 11A/e), showed congestion\n",
      "of the cerebral blood vessels, most of the pyramidal neurons appeared\n",
      "irregular darkly stained with pyknotic nuclei and surrounded by halos\n",
      "while others appeared shrunken necrotic and few appeared faintly\n",
      "stained ghost like with widely spread neuronophagia (Fig. 11A/f). The\n",
      "cerebral cortex of some animals showed hypercellularity (Fig. 11B/a),\n",
      "marked vacuolation of the neuropil with apparent neuronal vacuolar\n",
      "degeneration and necrosis as well as neuronophagia. Astrocytic reac-\n",
      "tion was noticed as swelling, edema and nuclear pyknosis. Apoptotic\n",
      "cells and bodies (Fig. 11B/b) were observed in all cases but of variable\n",
      "severity. Examination of brain tissue of the mice given tramadol and\n",
      "nicotine (Fig. 11B/c), revealed focal glial cells proliferation, marked\n",
      "shrinkage, vacuolar degeneration and necrosis of the neurons. Some\n",
      "\n",
      "necrotic neurons appeared as remnants (Fig. 11B/d) while others ap-\n",
      "peared with pyknotic nuclei or appeared ghost-like without any nuclear\n",
      "structure accompanied with many apoptotic cells and bodies. Neuro-\n",
      "nophagia (Fig. 11B/e), hyperactivity of astrocytes and vacuolation of\n",
      "neuropil were all noticed. Few mice showed perivascular cuffing of the\n",
      "congested cerebral vessels (Fig. 11B/f).\n",
      "\n",
      "4. Discussion\n",
      "\n",
      "In the current investigation we provide the first evidence, to au-\n",
      "thors′ knowledge, regarding the divergent behavioral/neurotoxic ef-\n",
      "fects of combining nicotine and tramadol. On one hand, tramadol in\n",
      "association with nicotine improved social interaction while decreasing\n",
      "anxiety and aggression linked to chronic administration of nicotine.\n",
      "However, on the other hand, this combination elicited negative effects\n",
      "regarding learning and memory consolidation. Tramadol and nicotine\n",
      "neurotoxic effects were investigated via assessment of different markers\n",
      "of oxidative stress, inflammation and apoptosis, in addition to histo-\n",
      "pathological examination of brain tissue.\n",
      "\n",
      "Prior to pursuing the neurochemical and neurobehavioral altera-\n",
      "tions induced by co-administration of tramadol and nicotine, it was\n",
      "imperative to determine whether nicotine had an effect on tramadol\n",
      "concentration in mice brain. Noteworthy, in the current investigation,\n",
      "nicotine induced a significant increase in tramadol concentration in\n",
      "\n",
      "Fig. 6. Photomicrograph depicting caspase-3 immunohistochemical staining in cerebral cortex, Brown color (positive) indicates specific immunostaining for caspase-\n",
      "3. Control group showed negative expression of caspase-3 (a). Both tramadol and nicotine elevated expression of caspase-3 immunoreactive positive cells as shown\n",
      "by the intense brown staining particularly in nicotine (b and c). Furthermore, co-administration of nicotine with tramadol elevated expression of caspase-3 im-\n",
      "munoreactive positive cells (d–e). The number of apoptotic cells (caspase-3 dependent) was determined by counting the number of positive cells in 5 randomly\n",
      "chosen microscopic fields at 40x objective magnification (f).\n",
      "\n",
      "Table 1\n",
      "Changes in cortical monoamines levels (DA, 5HT, NE, GLU, and GABA) induced by tramadol either alone or in combination with nicotine.\n",
      "\n",
      "Parameters\n",
      "\n",
      "Groups DA\n",
      "(μg/g.tissue)\n",
      "\n",
      "5 H T\n",
      "(μg/g.tissue)\n",
      "\n",
      "NE\n",
      "(μg/g.tissue)\n",
      "\n",
      "GLU\n",
      "(μg/g.tissue)\n",
      "\n",
      "GABA\n",
      "(μg/g.tissue)\n",
      "\n",
      "Control 0.95 ± 0.05 0.39 ± 0.05 0.48 ± 0.03 5.74 ± 0.3 6.33 ± 0.39\n",
      "Tramadol 1.57 ± 0.03* 0.65 ± 0.06* 0.58 ± 0.04* 7.14 ± 0.42* 10.72 ± 0.59*\n",
      "\n",
      "Nicotine 1.27 ± 0.08*# 0.34 ± 0.03# 0.69 ± 0.03*# 7.42 ± 0.30* 4.88 ± 0.50*#\n",
      "\n",
      "TR. +NI. 1.53 ± 0.03*@ 0.49 ± 0.05*#@ 0.56 ± 0.05*@ 10.32 ± 0.64*#@ 8.19 ± 0.19*#@\n",
      "\n",
      "Data are expressed as mean of (6–8) experiments ± SD. Statistical analyses were carried out by ANOVA followed by Tukey’s Multiple Comparison Test. *: significant\n",
      "from control, #: significant from tramadol, @: significant from nicotine at p < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "252\n",
      "\n",
      "\n",
      "\n",
      "mice brain after 30min of tramadol injection. The increment in tra-\n",
      "madol concentration induced by its co-administration with nicotine\n",
      "might lend a plausible explanation for the heightened mortality seen\n",
      "with the combination. The current findings can be explained in the light\n",
      "of study of Wang et al.(2015) who reported that nicotine altered tra-\n",
      "madol metabolism and increased Cmax of tramadol and M1 in cere-\n",
      "brospinal fluid in rats; an event that would be attributed to induction of\n",
      "brain CYP450 2D enzyme by nicotine and enhance tramadol metabo-\n",
      "lism. Moreover, the present results are supported with the study of\n",
      "Solarino et al. (2010) who reported multidrug poisoning case involving\n",
      "tramadol and nicotine and attributed the fatality to that nicotine en-\n",
      "hanced the effect of tramadol, suggesting that this combination may be\n",
      "toxic in large doses.\n",
      "\n",
      "In the present study, a significant increase in cortical oxidative/ni-\n",
      "trosative stress of mice subjected to tramadol and nicotine alone or in\n",
      "combination, reflected by increased TBARS and NO paralleled by de-\n",
      "creased NPSHs. Noteworthy, microglia, the brain resident macrophages\n",
      "presents one source for the increased ROS (Carniglia et al., 2017).\n",
      "\n",
      "Indeed, the present investigation outlines increased microglial im-\n",
      "munoreactivity as manifest by enhanced CD68 positive cells in mice\n",
      "receiving either treatment alone or in combination. These results are\n",
      "consistent with several lines of evidence which indicated that repeated\n",
      "administration of tramadol (Abdel-Zaher et al., 2011) and nicotine\n",
      "(Bhagwat et al.,1998; Gumustekin et al., 2003; Hritcu et al., 2009) in-\n",
      "creased oxidative stress in the brain. Furthermore, DA auto-oxidation\n",
      "could afford a second plausible theory explaining oxidative stress ac-\n",
      "companied with most of drugs of abuse (Cunha-Oliveira et al., 2013).\n",
      "DA quinones, which are electron-deficient molecules, can readily react\n",
      "with cysteinyl residues of proteins, such as GSH leading to glutathione\n",
      "depletion (Miyazaki and Asanuma, 2008); events that are supported by\n",
      "findings from this present report. Indeed, many studies reported that\n",
      "nicotine administration induced apoptosis in brain via increase of oxi-\n",
      "dative stress and moreover, nicotine was found to produce a remarkable\n",
      "loss of neurons in mid brain and cortex of adolescent rodents (Ferrea\n",
      "and Winterer, 2009; Hritcu et al., 2009).\n",
      "\n",
      "The production of reactive nitrogen species (RNS) such as the\n",
      "\n",
      "Fig. 7. Photomicrograph depicting TH immunohistochemical staining in mid brain, Brown color (positive) indicates specific immunostaining for tyrosine hydro-\n",
      "xylase. Control group showed minimal immunostaining for TH (a). Both of tramadol and nicotine elevated expression of TH (b and c). Moreover, co-administration\n",
      "of tramadol with nicotine elevated expression of TH as shown by the intense brown staining (d). Quantitative image analysis for immunohistochemical staining\n",
      "expressed as optical densities (OD) across 10 different fields for each mouse section (e).\n",
      "\n",
      "Fig. 8. Tramadol alone had no effect on cortical acetyl\n",
      "(a) and butyryl (b) cholinestrases while mice receiving\n",
      "nicotine alone showed increase in cortical acet-\n",
      "ylcholinestrase. Furthermore mice given nicotine with\n",
      "tramadol showed a significant increase in both en-\n",
      "zymes. Data are expressed as mean of (6–8)\n",
      "experiments ± SDM. Statistical analyses were carried\n",
      "out by ANOVA followed by Tukey’s Multiple\n",
      "Comparison Test. *: significant from control, #: sig-\n",
      "nificant from tramadol at p < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "253\n",
      "\n",
      "\n",
      "\n",
      "radical nitric oxide (NO) and its metabolite peroxynitrite (ONOO−)\n",
      "present another form of cellular stress (Hastings, 2009). In fact, the\n",
      "current investigation demonstrates increased NO by nicotine and/or\n",
      "tramadol subsequent to enhanced nNOS/iNOS content. Worthy of note,\n",
      "microglial cells produce not only NO but also a variety of proi-\n",
      "nflammatory cytokines (Carniglia et al., 2017). Certainly, the present\n",
      "study showed a significant increase in iNOS and TNF-α levels in cortices\n",
      "of mice subjected to tramadol and nicotine alone or in combination.\n",
      "Worth mentioning, the increase in case of tramadol/nicotine combi-\n",
      "nation was significant compared to tramadol or nicotine alone. The\n",
      "induction of these inflammatory mediators is mediated by several dif-\n",
      "ferent pathways, one important pathway is through NF-κB (Karin,\n",
      "2005). In fact, the present findings display augmented NF-κB, which is\n",
      "considered to be redox sensitive transcription factor (Gloire et al.,\n",
      "2006) that could have been activated by the present increase in ROS.\n",
      "NF-κB influences the expression of genes encoding proinflammatory\n",
      "cytokines in microglial cells like TNF-α and iNOS as well (Mattson and\n",
      "Camandola, 2001). In addition, TNF-α may indirectly increase iNOS in\n",
      "an NF-κB independent pathway thus adding to the proxidant milieu\n",
      "\n",
      "(Nassar et al.,2015). Worth mentioning, the increment in TNF-α ob-\n",
      "served in this study could lend credence to the observed reduction in\n",
      "body weight seen in the current investigation with the three different\n",
      "regimens. Certainly, increased serum TNF-α inhibits the uptake of cir-\n",
      "culating free fatty acids and accelerates lipolysis in adipose tissue\n",
      "(Kirana et al., 2011; Georgy et al., 2013).\n",
      "\n",
      "The current investigation displays an increased number of Casp-3\n",
      "positive cells in groups receiving either tramadol or nicotine alone or in\n",
      "combination. Noteworthy, the observed increment in ROS as well as\n",
      "proinflammatory cytokines induce apoptotic cascades through intrinsic\n",
      "and extrinsic pathways (Dong et al., 2009). Moreover, the current in-\n",
      "vestigation displays an increment in GLU, iNOS and nNOS. Indeed\n",
      "glutamatergic neurotransmission has been implicated in several pro-\n",
      "cesses involved in drug addiction, including reinforcement, sensitiza-\n",
      "tion, habit learning, craving, and relapse (Tzschentke and Schmidt,\n",
      "2003). In a feed-forward cycle, GLU induced excitotoxicity is caused by\n",
      "a massive influx of extracellular Ca2+ resulting from the overactivation\n",
      "of the N-methyl- D-aspartate (NMDA) GLU receptors which further\n",
      "contributes to stress burden and hence Casp-3 activation (Zhang and\n",
      "\n",
      "Fig. 9. Mice given tramadol and nicotine alone or in\n",
      "combination showed a disturbed performance in\n",
      "MWM (a); the time spent in the target quadrant was\n",
      "significantly less in groups receiving the aforemen-\n",
      "tioned drugs in probe test (b); tramadol alone showed\n",
      "no change in defensive aggression and social interac-\n",
      "tion tests (c–d), nicotine treated mice displayed in-\n",
      "creased aggression score and decreased (SI) time\n",
      "(c–d), however mice given tramadol in addition to\n",
      "nicotine showed decrease in aggression and increase in\n",
      "(SI) time compared to nicotine per se (c–d). Data are\n",
      "expressed as mean of (6–8) experiments ± SD.\n",
      "Statistical analyses were carried out by two way\n",
      "ANOVA followed by Bonferroni post test for MWM\n",
      "learning curve (a) and one way ANOVA followed by\n",
      "Tukey’s Multiple Comparison Test for probe test\n",
      "(b),aggression (c),social interaction (d) *: significant\n",
      "from control, #: significant from tramadol, @: sig-\n",
      "nificant from nicotine at p < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "254\n",
      "\n",
      "\n",
      "\n",
      "Bhavnani, 2006). Consequent to the excitotoxicity exerted by GLU, the\n",
      "rise intracellular Ca2+can stimulate nNOS through interaction with\n",
      "calmodulin resulting in massive increase in NO level, which in turn can\n",
      "react with O2\n",
      "\n",
      ".− to form toxic ONOO- (Parathath et al., 2007; Dong\n",
      "et al., 2009; Cunha-Oliveira et al., 2013) to further exacerbate the free\n",
      "radical pool in addition to the observed changes seen with iNOS; thus\n",
      "implicating both isoenzymes in the damage exerted by tramadol and\n",
      "nicotine either alone or in combination.\n",
      "\n",
      "The aforementioned abnormalities and biochemical data were fur-\n",
      "ther confirmed by histopathological examination of the brain cortices.\n",
      "The brain sections of mice receiving tramadol showed vacuolar de-\n",
      "generation and necrosis of some pyramidal neurons in addition to few\n",
      "apoptotic bodies. These histopathological changes are consistent with\n",
      "those reported by Atici et al. (2004) who found that chronic use of\n",
      "tramadol caused neuron degeneration which may lead to cerebral\n",
      "dysfunction. Moreover, consistent with oxidative/nitroactive stress,\n",
      "exaggerated inflammation and excitotoxicity reported herein following\n",
      "nicotine administration, the cerebral cortex of such mice showed hy-\n",
      "percellularity, marked vacuolation of the neuropil, astrocytic reaction\n",
      "and apoptotic bodies. Furthermore, administration of tramadol with\n",
      "\n",
      "nicotine caused focal glial cells proliferation, hyperactivity of astro-\n",
      "cytes, vacuolar degeneration and necrosis of the neurons. These results\n",
      "support our findings concerning activation of microglial cells by ROS\n",
      "induced by tramadol and nicotine which sequentially lead to release of\n",
      "inflammatory cytokines/superoxide anion and at last apoptosis.\n",
      "\n",
      "Dopaminergic neurons are prone to oxidative stress due to their\n",
      "high rate of oxygen metabolism, low levels of antioxidants, and high\n",
      "iron content (Halliwell, 1992). Paradoxically, this study showed that\n",
      "administration of tramadol and nicotine either alone or in combination\n",
      "resulted in a significant increase in cortical DA level, paralleled with the\n",
      "increased expression of TH in midbrain region. Our results are sup-\n",
      "ported by study of Nakamura et al. (2008) which reported, that tra-\n",
      "madol increased DA level via activation of μ-opioid receptors, expressed\n",
      "in ventral tegmental area (VTA) in midbrain region and potentiation of\n",
      "mesolimbic pathway. Other studies also reported that nicotine can sti-\n",
      "mulate mesocorticolimbic system and enhance DA release by direct\n",
      "stimulation of nicotinic receptors in VTA (Koob and Le Moal, 2008;\n",
      "Cachope and Cheer, 2014). Furthermore, experimental evidence outlies\n",
      "a co-modulatory effect for that nicotine and opioids, where nicotine was\n",
      "found to induce DA release through activation of μ-opioid receptors in\n",
      "\n",
      "Fig. 10. Tramadol produced a significant decrease in\n",
      "thigmotaxis time (a) paralleled with increase in cen-\n",
      "tral square frequency (b) in addition to increase in\n",
      "ambulation (c), rearing (d) and grooming (e) fre-\n",
      "quencies. Nicotine alone induced a significant increase\n",
      "in grooming frequency (e) and had no change on other\n",
      "parameters (a–d). Mice receiving tramadol with nico-\n",
      "tine displayed a significant decrease in thigmotaxis\n",
      "time (a) accompanied with increase in central square\n",
      "frequency (b) compared to nicotine alone, in addition\n",
      "to a significant increase in grooming frequency (e)\n",
      "compared to tramadol or nicotine. Data are expressed\n",
      "as mean of (6–8) experiments ± SD. Statistical ana-\n",
      "lyses were carried out by ANOVA followed by Tukey’s\n",
      "Multiple Comparison Test. *: significant from control,\n",
      "#: significant from tramadol, @: significant from ni-\n",
      "cotine at p < 0.05.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "255\n",
      "\n",
      "\n",
      "\n",
      "the VTA (Tanda and Di Chiara, 1998; Skurtveit et al., 2010). In addi-\n",
      "tion, another study highlighted the existence for a mechanistic overlap\n",
      "between opiates and nicotine within DA reward pathway (Britt and\n",
      "McGehee, 2008). Consequently, our results may explain one of the\n",
      "\n",
      "possible mechanisms underlying reward, addiction and dependence\n",
      "regarding tramadol and nicotine via potentiation of mesocortical\n",
      "pathway and increase DA levels.\n",
      "\n",
      "However, one might argue against the discrepancy of enhanced\n",
      "\n",
      "Fig. 11. A: Photomicrographs depicting the histo-\n",
      "logical appearance of cerebral cortices (CX) of con-\n",
      "trol mice showing normal histological structure (a).\n",
      "Mice given tramadol (20mg/kg) (b–d) showing;\n",
      "neuronal vacuolar degeneration (arrow), few apop-\n",
      "totic bodies (short arrow) and necrosis with neuro-\n",
      "nophagia (dashed arrow) (c–d). Mice subjected to\n",
      "nicotine (0.25mg/kg) (e–f) showing; darkly stained\n",
      "neurons with pyknotic nuclei, others shrunken ne-\n",
      "crotic and few ghost like (arrow) with marked\n",
      "neuronophagia (dashed arrow) (f) (H&E). B: CX of\n",
      "mice subjected to nicotine (0.25mg/kg) (a–b)\n",
      "showing; hypercellularity (a), apparent neuronal\n",
      "vacuolar degeneration (arrow) and necrosis as well\n",
      "as apoptotic cells and bodies (dashed arrow) (b). CX\n",
      "of mice given combined tramadol and nicotine (c–f)\n",
      "showing; marked shrinkage and necrosis of the\n",
      "neurons (arrow) with remenents of necrotic cells\n",
      "(short arrow) (d) and marked neuronophagia (da-\n",
      "shed arrow), neuronoal vacuolar degeneration (e),\n",
      "many apoptotic cells and bodies (arrow head) and\n",
      "perivascular cuffing (double-line arrow) of the cer-\n",
      "ebral vessels (f) (H&E).\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "256\n",
      "\n",
      "\n",
      "\n",
      "Casp-3 versus the preservation of DA neurons. Albeit, evidence suggests\n",
      "that an increment in GLU was observed consequent to Casp-3 that\n",
      "further contributes to increased addiction (Kenny, 2011) and hence\n",
      "increased DA content consequent to TH expression; events seen in all\n",
      "treatments in the present study.\n",
      "\n",
      "Cholinergic neurons of the basal forebrain with its extensive cortical\n",
      "projections play a crucial role in cognitive and behavioral functions\n",
      "(Giacobini, 2003). In our study, mice subjected to nicotine showed a\n",
      "significant increase in AChE level, whereas mice receiving tramadol and\n",
      "nicotine showed a significant increase in both AChE and BuChE activ-\n",
      "ities; corroborating with the disrupted performance observed in MWM\n",
      "test and memory consolidation. Indeed, a study by (Hu et al., 2009)\n",
      "revealed increased AChE in relation to increase Casp-3 expression and\n",
      "apoptosis in brain. Accordingly, in the present investigation the surge in\n",
      "AChE accompanied with the enhanced expression of Casp-3 in nicotine\n",
      "and nicotine/tramadol treated mice lend credence to the involvement\n",
      "of apoptosis in cognitive impairment induced by nicotine or tramadol/\n",
      "nicotine. On a closer look, AChE was not elevated with tramadol alone\n",
      "which would seemingly oppose the changes in MWM seen with the sole\n",
      "tramadol administration. One plausible explanation for this observation\n",
      "might be attributed to the present enhancement of cortical 5 H T and\n",
      "GABA, which have been shown previously to impair memory function\n",
      "(Fontana et al., 1995; Hosseini-Sharifabad et al., 2016).\n",
      "\n",
      "The cortical area is not only involved in reward processing and\n",
      "cognitive functions, but also moderates social behavior, mood as well as\n",
      "anxiety (Martin et al., 2009). Noteworthy, such disorders are mediated\n",
      "by a plethora of neurotransmitter/amino acids disruptions. In the pre-\n",
      "sent study, mice subjected to tramadol showed a significant increase in\n",
      "cortical serotonin, NE and GABA levels. Moreover, tramadol treated\n",
      "mice showed anxiolytic behavior in OFT which was manifested by\n",
      "significant decrease in thigmotaxis time paralleled with increase in\n",
      "central square frequency. In addition, tramadol showed a significant\n",
      "increase in ambulation, rearing and grooming frequencies. The current\n",
      "findings are supported by study of Gholami et al. (2014) who reported\n",
      "that chronic tramadol re-exposure resulted in marked anxiolytic-like\n",
      "behaviors due to the ability of tramadol to inhibit 5 H T and NE re-\n",
      "uptake in brain (Faron-Gorecka et al., 2004). Worthy of note, the role of\n",
      "GABA has long been regarded as central to the regulation of anxiety and\n",
      "this neurotransmitter system is the target for many drugs used for\n",
      "treatment of anxiety disorders (Nuss, 2015).\n",
      "\n",
      "Nicotine anxiogenic like effects could be mediated by enhancement\n",
      "of the release of some neurotransmitters such as, GLU and NE which are\n",
      "known to facilitate stress/anxiety related behavior (Balerio et al.,\n",
      "2005). Consistent with previous findings, in the current investigation,\n",
      "nicotine exposed mice showed a significant increase in cortical NE and\n",
      "GLU levels paralleled with decrease in GABA levels. Noteworthy, stu-\n",
      "dies reported that decreased GABA levels are associated with mood and\n",
      "anxiety disorders (Kent et al., 2002). These changes in neuro-\n",
      "transmitters and GLU levels were reflected by increased anxiogenic\n",
      "behavior in OFT as manifested with increase thigmotaxis time paral-\n",
      "leled with decrease central square frequency. In addition, there was a\n",
      "significant increase in grooming frequency reflecting the increase in DA\n",
      "level (Kalueff et al., 2016).\n",
      "\n",
      "HT and NE play a crucial role in modulating aggressive behavior.\n",
      "Elevated NE or decreased GABA levels may develop aggression\n",
      "(Eichelman, 1990). Moreover, increased excitatory glutaminergic ac-\n",
      "tivity is associated with social anxiety disorders (Martin et al., 2009).\n",
      "By the same token, mice receiving nicotine showed aggressive behavior\n",
      "and decrease in social interaction which may be attributed to decrease\n",
      "GABA levels and step up in NE and GLU levels. Interestingly, mice\n",
      "subjected to tramadol and nicotine showed a significant increase in\n",
      "cortical 5 H T and GABA levels at the same time as decreasing in NE\n",
      "level compared to nicotine per se and this was reflected in behavior\n",
      "tests as decreased in anxiety and aggressive behavior in addition to\n",
      "improvement in social interaction test compared to mice subjected to\n",
      "nicotine only. However, tramadol alone had no effect on defensive\n",
      "\n",
      "aggression or social interaction tests.\n",
      "Taken all together; findings from the present study provide com-\n",
      "\n",
      "pelling evidence for neurotoxic effects associated with co-administra-\n",
      "tion of tramadol and nicotine despite enhanced reward manifested as\n",
      "increased DA and TH. Indeed, neurotoxicity is mediated through in-\n",
      "crease oxidative/nitrosative stress and enhanced levels of NO via in-\n",
      "duction of nNOS consequent to increments in GLU and iNOS down-\n",
      "stream from NF-κB, TNF-α leading to neuroinflammation and at last\n",
      "apoptosis. Correlatively, the neuroinflammation and Casp-3 activation\n",
      "may contribute to the memory deficits induced by tramadol and nico-\n",
      "tine. However, administration of tramadol and nicotine improved social\n",
      "interaction while decreasing anxiety and aggression associated with\n",
      "chronic administration of nicotine. Hence, many smokers tend to abuse\n",
      "tramadol as a phenomenal behavior, to reduce aggression and anxiety\n",
      "linked to nicotine while enhancing reward, however, such combination\n",
      "exacerbated neurotoxic effects and elicited negative effects regarding\n",
      "learning and memory.\n",
      "\n",
      "Conflict of interest\n",
      "\n",
      "None.\n",
      "\n",
      "References\n",
      "\n",
      "Abdel-Zaher, A.O., Abdel-Rahman, M.S., Elwasei, F.M., 2011. Protective effect of Nigella\n",
      "sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric\n",
      "oxide and oxidative stress. Neurotoxicology 32, 725–733.\n",
      "\n",
      "Atici, S., Cinel, L., Cinel, I., Doruk, N., Aktekin, M., Akca, A., Camdeviren, H., Oral, U.,\n",
      "2004. Opioid neurotoxicity: comparison of morphine and tramadol in an experi-\n",
      "mental rat model. Int. J. Neurosci. 114, 1001–1011.\n",
      "\n",
      "Bailey, R.K., Crawley, N.J., 2009. Anxiety-related behaviors in mice. In: Buccafusco, J.J.\n",
      "(Ed.), Methods of Behavior Analysis in Neuroscience, 2nd edition. Boca Raton (FL).\n",
      "\n",
      "Balconi, M., Finocchiaro, R., Campanella, S., 2014. Reward sensitivity, decisional bias,\n",
      "and metacognitive deficits in cocaine drug addiction. J. Addict. Med. 8, 399–406.\n",
      "\n",
      "Balerio, G.N., Aso, E., Maldonado, R., 2005. Involvement of the opioid system in the\n",
      "effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology\n",
      "(Berl). 181, 260–269.\n",
      "\n",
      "Bancroft, J.D., Gamble, M., 2008. Theory and Practice of Histological Techniques, 6th ed.\n",
      "Elsevier, Churchill Livingstone. China.\n",
      "\n",
      "Berrendero, F., Robledo, P., Trigo, J.M., Martin-Garcia, E., Maldonado, R., 2010.\n",
      "Neurobiological mechanisms involved in nicotine dependence and reward: partici-\n",
      "pation of the endogenous opioid system. Neurosci. Biobehav Rev. 35, 220–231.\n",
      "\n",
      "Beutler, E., Duron, O., Kelly, B.M., 1963. Improved method for the determination of blood\n",
      "glutathione. J. Lab Clin. Med. 61, 882–888.\n",
      "\n",
      "Bhagwat, S.V., Vijayasarathy, C., Raza, H., Mullick, J., Avadhani, N.G., 1998. Preferential\n",
      "effects of nicotine and 4-(N-methyl-N-nitrosamine)-1-(3-pyridyl)-1-butanone on mi-\n",
      "tochondrial glutathione S-transferase A4-4 induction and increased oxidative stress in\n",
      "the rat brain. Biochem Pharmacol. 56, 831–839.\n",
      "\n",
      "Britt, J.P., McGehee, D.S., 2008. Presynaptic opioid and nicotinic receptor modulation of\n",
      "dopamine overflow in the nucleus accumbens. J. Neurosci. 28, 1672–1681.\n",
      "\n",
      "Bromley-Brits, K., Deng, Y., Song, W., 2011. Morris Water maze test for learning and\n",
      "memory deficits in Alzheimer’s disease model mice. J. Vis. Exp. 53, e2920.\n",
      "\n",
      "Cachope, R., Cheer, J.F., 2014. Local control of striatal dopamine release. Front. Behav.\n",
      "Neurosci. 8, 188.\n",
      "\n",
      "Carniglia, L., Ram´ırez, D., Durand, D., Saba, J., Turati, J., Caruso, C., Scimonelli, N.T.,\n",
      "Mercedes, L., 2017. Neuropeptides and microglial activation in inflammation, pain\n",
      "and neurodegenerative diseases. Mediators Inflamm. 2017, 1–23.\n",
      "\n",
      "Cunha-Oliveira, T., Rego, A.C., Catarina, R.O., 2013. Oxidative stress And drugs of abuse:\n",
      "an update. Mini-Reviews Org. Chem. 10, 1–14.\n",
      "\n",
      "Dong, X.X., Wang, Y., Qin, Z., 2009. Molecular mechanisms of excitotoxicity and their\n",
      "relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 30,\n",
      "379–387.\n",
      "\n",
      "Dwoskin, L.P., Smith, A.M., Wooters, T.E., Zhang, Z., Crooks, P.A., Bardo, M.T., 2009.\n",
      "Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem\n",
      "Pharmacol. 78, 732–743.\n",
      "\n",
      "Eichelman, B.S., 1990. Neurochemical and psychopharmacologic aspects of aggressive\n",
      "behavior. Annu Rev. Med. 41, 149–158.\n",
      "\n",
      "Elkader, A.K., Brands, B., Selby, P., Sproule, B.A., 2009. Methadone-nicotine interactions\n",
      "in methadone maintenance treatment patients. J. Clin. Psychopharmacol. 29,\n",
      "231–238.\n",
      "\n",
      "Ellman, G.L., 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82, 70–77.\n",
      "Ellman, G.L., Courtney, K.D., Andres Jr, V., Feather-Stone, R.M., 1961. A new and rapid\n",
      "\n",
      "colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7,\n",
      "88–95.\n",
      "\n",
      "Epstein, D.H., Marrone, G.F., Heishman, S.J., Schmittner, J., Preston, K.L., 2010. Tobacco,\n",
      "cocaine, and heroin: craving and use during daily life. Addict. Behav. 35, 318–324.\n",
      "\n",
      "Faron-Gorecka, A., Kusmider, M., Inan, S.Y., Siwanowicz, J., Piwowarczyk, T.,\n",
      "Dziedzicka-Wasylewska, M., 2004. Long-term exposure of rats to tramadol alters\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "257\n",
      "\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0005\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0005\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0005\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0010\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0010\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0010\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0015\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0015\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0020\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0020\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0025\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0025\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0025\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0030\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0030\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0035\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0035\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0035\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0040\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0040\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0045\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0045\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0045\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0045\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0050\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0050\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0055\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0055\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0060\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0060\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0065\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0065\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0065\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0070\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0070\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0075\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0075\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0075\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0080\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0080\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0080\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0085\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0085\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0090\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0090\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0090\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0095\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0100\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0100\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0100\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0105\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0105\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0110\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0110\n",
      "\n",
      "\n",
      "brain dopamine and alpha 1-adrenoceptor function that may be related to anti-\n",
      "depressant potency. Eur J. Pharmacol. 501, 103–110.\n",
      "\n",
      "Ferrea, S., Winterer, G., 2009. Neuroprotective and neurotoxic effects of nicotine.\n",
      "Pharmacopsychiatry 42, 255–265.\n",
      "\n",
      "Fontana, D.J., Daniels, S.E., Henderson, C., Eglen, R.M., Wong, E.H., 1995. Ondansetron\n",
      "improves cognitive performance in the Morris water maze spatial navigation task.\n",
      "Psychopharmacology 120, 409–417.\n",
      "\n",
      "Frosch, D.L., Shoptaw, S., Nahom, D., Jarvik, M.E., 2000. Associations between tobacco\n",
      "smoking and illicit drug use among methadone maintained opiate-dependent in-\n",
      "dividuals. Exp Clin Psychopharmacol. 8, 97–103.\n",
      "\n",
      "Georgy, G.S., Nassar, N.N., Mansour, H.A., Abdallah, D.M., 2013. Cerebrolysin\n",
      "Ameloriates Cognitive Deficits in Type III Diabetic Rats. PLoS One 8, e64847.\n",
      "\n",
      "Gholami, M., Saboory, E., Khalkhali, H.R., 2014. Chronic morphine and tramadol re-\n",
      "exposure induced an anti-anxiety effect in prepubertal rats exposed neonatally to the\n",
      "same drugs. Clin. Exp. Pharmacol. Physiol. 41, 838–843.\n",
      "\n",
      "Giacobini, E., 2003. Cholinergic function and alzheimer’s disease. Int. J. Geriatr\n",
      "Psychiatry. 18, S1–S5.\n",
      "\n",
      "Gibson, T.P., 1996. Pharmacokinetics, efficacy, and safety of analgesia with a focus on\n",
      "tramadol HCl. Am. J. Med. 101 (1A), 47S–53S.\n",
      "\n",
      "Gloire, G., Legrand-Poels, S., Piette, J., 2006. NF-kappaB activation by reactive oxygen\n",
      "species: fifteen years later. Biochem Pharmacol. 72, 1493–1505.\n",
      "\n",
      "Gorun, V., Proinov, I., Baltescu, V., Balaban, G., Barzu, O., 1978. Modified Ellman pro-\n",
      "cedure for assay of cholinesterases in crude enzymatic preparations. Anal. Biochem.\n",
      "86, 324–326.\n",
      "\n",
      "Gumustekin, K., Altinkaynak, K., Timur, H., Taysi, S., Oztasan, N., Polat, F.M., Akcay, F.,\n",
      "Suleyman, H., Dane, S., Gul, M., 2003. Vitamin E but not Hippophea rhamnoides L.\n",
      "prevented nicotine-induced oxidative stress in rat brain. Hum. Exp. Toxicol. 22,\n",
      "425–431.\n",
      "\n",
      "Halliwell, B., 1992. Reactive oxygen species and the central nervous system. J.\n",
      "Neurochem. 59, 1609–1623.\n",
      "\n",
      "Hastings, T.G., 2009. The role of dopamine oxidation in mitochondrial dysfunction: im-\n",
      "plications for Parkinson’s disease. J. Bioenerg. Biomembr. 41, 469–472.\n",
      "\n",
      "Heinrikson, R.L., Meredith, S.C., 1984. Amino acid analysis by reverse-phase high-per-\n",
      "formance liquid chromatography: precolumn derivatization with phenylisothiocya-\n",
      "nate. Anal. Biochem. 136, 65–74.\n",
      "\n",
      "Hosseini-Sharifabad, A., Rabbani, M., Sharifzadeh, M., Bagheri, N., 2016. Acute and\n",
      "chronic tramadol administration impair spatial memory in rat. Res. Pharm. Sci. 11,\n",
      "49–57.\n",
      "\n",
      "Hritcu, L., Ciobica, A., Gorgan, L., 2009. Nicotine-induced memory impairment by in-\n",
      "creasing brain oxidative stress. Central Eur. J. Biol. 4, 335–342.\n",
      "\n",
      "Hsu, S.M., Raine, L., Fanger, H., 1981. The use of antiavidin antibody and avidin-biotin-\n",
      "peroxidase complex in immunoperoxidase technics. Am J. Clin. Pathol. 75, 816–821.\n",
      "\n",
      "Hu, T., Fu, Q., Liu, X., Zhang, H., Dong, M., 2009. Increased acetylcholinesterase and\n",
      "capase-3 expression in the brain and peripheral immune system of focal cerebral\n",
      "ischemic rats. J. Neuroimmunol. 211, 84–91.\n",
      "\n",
      "ILAR, 1996. Guide for the Care and Use of Laboratory Animals. NIH Publication No.\n",
      "85–23. National Academy Press, Washington, D.C.\n",
      "\n",
      "Johansson, P., Lindqvist, A., Nyberg, F., Fahlke, C., 2000. Anabolic androgenic steroids\n",
      "affects alcohol intake, defensive behaviors and brain opioid peptides in the rat.\n",
      "Pharmacol. Biochem Behav. 67, 271–279.\n",
      "\n",
      "Kalueff, A.V., Stewart, A.M., Song, C., Berridge, K.C., Graybiel, A.M., Fentress, J.C., 2016.\n",
      "Neurobiology of rodent self-grooming and its value for translational neuroscience.\n",
      "Nat. Rev. Neurosci. 17, 45–59.\n",
      "\n",
      "Karin, M., 2005. Inflammation-activated protein kinases as targets for drug development.\n",
      "Proc. Am. Thorac. Soc. 2, 386–390 discussion 394-385.\n",
      "\n",
      "Kenny, P.J., 2011. Common cellular and molecular mechanisms in obesity and drug ad-\n",
      "diction. Nat. Rev. Neurosci. 12, 638–651.\n",
      "\n",
      "Kent, J.M., Mathew, S.J., Gorman, J.M., 2002. Molecular targets in the treatment of\n",
      "anxiety. Biol Psychiatry. 52, 1008–1030.\n",
      "\n",
      "Kirana, H., Jali, M.V., Srinivasan, B.P., 2011. The study of aqueous extract of Ficus re-\n",
      "ligiosa Linn. On cytokine TNF-alpha in type 2 diabetic rats. Pharmacognosy Res. 3,\n",
      "30–34.\n",
      "\n",
      "Knedel, M., Bottger, R., 1967. [A kinetic method for determination of the activity of\n",
      "pseudocholinesterase (acylcholine acyl-hydrolase 3.1.1.8.)]. Klin Wochenschr. 45,\n",
      "325–327.\n",
      "\n",
      "Koob, G.F., Le Moal, M., 2008. Review. Neurobiological mechanisms for opponent mo-\n",
      "tivational processes in addiction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363,\n",
      "3113–3123.\n",
      "\n",
      "Lewis, A., Miller, J.H., Lea, R.A., 2007. Monoamine oxidase and tobacco dependence.\n",
      "Neurotoxicology 28, 182–195.\n",
      "\n",
      "Liu, Z.M., Zhou, W.H., Lian, Z., Mu, Y., Ren, Z.H., Cao, J.Q., Cai, Z.J., 1999. Drug de-\n",
      "pendence and abuse potential of tramadol. Acta Pharmacol. Sin. 20 (1), 52–54.\n",
      "\n",
      "Martin, E.I., Ressler, K.J., Binder, E., Nemeroff, C.B., 2009. The neurobiology of anxiety\n",
      "\n",
      "disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatr Clin.\n",
      "North. Am. 32, 549–575.\n",
      "\n",
      "Mattson, M.P., Camandola, S., 2001. NF-kappaB in neuronal plasticity and neurodegen-\n",
      "erative disorders. J. Clin. Invest. 107, 247–254.\n",
      "\n",
      "Mihara, M., Uchiyama, M., 1978. Determination of malonaldehyde precursor in tissues by\n",
      "thiobarbituric acid test. Anal. Biochem. 86, 271–278.\n",
      "\n",
      "Miranda, K.M., Espey, M.G., Wink, D.A., 2001. A rapid, simple spectrophotometric\n",
      "method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 5, 62–71.\n",
      "\n",
      "Miyazaki, I., Asanuma, M., 2008. Dopaminergic neuron-specific oxidative stress caused\n",
      "by dopamine itself. Acta Med. Okayama. 62, 141–150.\n",
      "\n",
      "Nakamura, A., Narita, M., Miyoshi, K., Shindo, K., Okutsu, D., Suzuki, M., Suzuki, T.,\n",
      "2008. Changes in the rewarding effects induced by tramadol and its active metabolite\n",
      "M1 after sciatic nerve injury in mice. Psychopharmacology. 200 (3), 307–316.\n",
      "\n",
      "Nassar, N.N., Al-Shorbagy, M.Y., Arab, H.H., Abdallah, D.M., 2015. Saxagliptin: a novel\n",
      "antiparkinsonian approach. Neuropharmacology. 89, 308–317.\n",
      "\n",
      "Niijima-Yaoita, F., Tsuchiya, M., Saito, H., Nagasawa, Y., Murai, S., Arai, Y.,\n",
      "Nakagawasai, O., Nemoto, W., Tadano, T., Tan-No, K., 2013. Influence of a long-term\n",
      "powdered diet on the social interaction test and dopaminergic systems in mice.\n",
      "Neurochem Int. 63, 309–315.\n",
      "\n",
      "Nossaman, V.E., Ramadhyani, U., Kadowitz, P.J., Nossaman, B.D., 2010. Advances in\n",
      "perioperative pain management: use of medications with dual analgesic mechanisms,\n",
      "tramadol and tapentadol. Anesthesiol. Clin. 28, 647–666.\n",
      "\n",
      "Nuss, P., 2015. Anxiety disorders and GABA neurotransmission: a disturbance of mod-\n",
      "ulation. Neuropsychiatr Dis. Treat. 11, 165–175.\n",
      "\n",
      "Pagel, P., Blome, J., Wolf, H.U., 2000. High-performance liquid chromatographic se-\n",
      "paration and measurement of various biogenic compounds possibly involved in the\n",
      "pathomechanism of parkinson’s disease. J. Chromatogr. B Biomed. Sci. Appl. 746,\n",
      "297–304.\n",
      "\n",
      "Parathath, S.R., Gravanis, I., Tsirka, S.E., 2007. Nitric oxide synthase isoforms undertake\n",
      "unique roles during excitotoxicity. Stroke 38, 1938–1945.\n",
      "\n",
      "Raffa, R.B., 2008. Basic pharmacology relevant to drug abuse assessment: tramadol as\n",
      "example. J. Clin. Pharm. Ther. 33, 101–108.\n",
      "\n",
      "Raffa, R.B., Friderichs, E., Reimann, W., Shank, R.P., Codd, E.E., Vaught, J.L., 1992.\n",
      "Opioid and nonopioid components independently contribute to the mechanism of\n",
      "action of tramadol, an’ atypical’ opioid analgesic. J. Pharmacol. Exp. Ther. 260,\n",
      "275–285.\n",
      "\n",
      "Shalaby, A.S., Sweilum, O.A., Ads, M.K., 2015. Does tramadol increase the severity of\n",
      "nicotine dependence? A study in an Egyptian sample. J. Psychoact. Drugs. 47,\n",
      "197–202.\n",
      "\n",
      "Sheikholeslami, B., Jamali, B., Mohammadreza, R., 2016. In: In: Preedy, V.R. (Ed.),\n",
      "Tramadol, Usage, Misuse, and Addiction Processes In Neuropathology of Drug\n",
      "Addictions and Substance Misuse 3. Academic Press, pp. 407–416.\n",
      "\n",
      "Shoaib, M., 2006. Effects of isoarecolone, a nicotinic receptor agonist in rodent models of\n",
      "nicotine dependence. Psychopharmacology. 188, 252–257.\n",
      "\n",
      "Simonsen, K.W., Edvardsen, H.M., Thelander, G., Ojanpera, I., Thordardottir, S.,\n",
      "Andersen, L.V., Kriikku, P., Vindenes, V., Christoffersen, D., Delaveris, G.J.M., Frost,\n",
      "J., 2015. Fatal poisoning in drug addicts in the nordic countries in 2012. Forensic Sci.\n",
      "Int. 248, 172–180.\n",
      "\n",
      "Skurtveit, S., Furu, K., Selmer, R., Handal, M., Tverdal, A., 2010. Nicotine dependence\n",
      "predicts repeated use of prescribed opioids. Prospective population-based cohort\n",
      "study. Ann. Epidemiol. 20, 890–897.\n",
      "\n",
      "Solarino, B., Riesselmann, B., Buschmann, C.T., Tsokos, M., 2010. Multidrug poisoning\n",
      "involving nicotine and tramadol. Forensic Sci. Int. 194, e17–19.\n",
      "\n",
      "Tanda, G., Di Chiara, G., 1998. A dopamine-mu1 opioid link in the rat ventral tegmentum\n",
      "shared by palatable food (fonzies) and non-psychostimulant drugs of abuse. Eur J.\n",
      "Neurosci. 10, 1179–1187.\n",
      "\n",
      "Tao, Q., Stone Jr, Dennis J., Borenstein, M.R., Jean-Bart, V., Codd, E.E., Coogan, T.P.,\n",
      "Desai-Krieger, D., Liao, S., Raffa, R.B., 2001. Gas chromatographic method using\n",
      "nitrogen-phosphorus detection for the measurement of tramadol and its o-desmethyl\n",
      "metabolite in plasma and brain tissue of mice and rats. J. Chromatogr. B Biomed. Sci.\n",
      "Appl. 763, 165–171.\n",
      "\n",
      "Tzschentke, T.M., Schmidt, W.J., 2003. Glutamatergic mechanisms in addiction. Mol.\n",
      "Psychiatry. 8, 373–382.\n",
      "\n",
      "Wang, Q., Han, X., Li, J., Gao, X., Wang, Y., Liu, M., Dong, G., Yue, J., 2015. Regulation of\n",
      "cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol\n",
      "with propranolol and nicotine. Xenobiotica. 45, 335–344.\n",
      "\n",
      "Zhang, Y., Bhavnani, B.R., 2006. Glutamate-induced apoptosis in neuronal cells is\n",
      "mediated via caspase-dependent and independent mechanisms involving calpain and\n",
      "caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is\n",
      "inhibited by equine estrogens. BMC Neurosci. 7, 49.\n",
      "\n",
      "Zhuo, H.Q., Huang, L., Huang, H.Q., Cai, Z., 2012. Effects of chronic tramadol exposure\n",
      "on the zebrafish brain: a proteomic study. J. Proteom. 75, 3351–3364.\n",
      "\n",
      "S.M. Azmy et al. Neurotoxicology 67 (2018) 245–258\n",
      "\n",
      "258\n",
      "\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0110\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0110\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0115\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0115\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0120\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0120\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0120\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0125\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0125\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0125\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0130\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0130\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0135\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0135\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0135\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0140\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0140\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0145\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0145\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0150\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0150\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0155\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0155\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0155\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0160\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0160\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0160\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0160\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0165\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0165\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0170\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0170\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0175\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0175\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0175\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0180\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0180\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0180\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0185\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0185\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0190\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0190\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0195\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0195\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0195\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0200\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0200\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0205\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0205\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0205\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0210\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0210\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0210\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0215\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0215\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0220\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0220\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0225\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0225\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0230\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0230\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0230\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0235\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0235\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0235\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0240\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0240\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0240\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0245\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0245\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0250\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0250\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0255\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0255\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0255\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0260\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0260\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0265\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0265\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0270\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0270\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0275\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0275\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0280\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0280\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0280\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0285\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0285\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0290\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0290\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0290\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0290\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0295\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0295\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0295\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0300\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0300\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0305\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0305\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0305\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0305\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0310\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0310\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0315\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0315\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0320\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0320\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0320\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0320\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0325\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0325\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0325\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0330\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0330\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0330\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0335\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0335\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0340\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0340\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0340\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0340\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0345\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0345\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0345\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0350\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0350\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0355\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0355\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0355\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0360\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0360\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0360\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0360\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0360\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0365\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0365\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0370\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0370\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0370\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0375\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0375\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0375\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0375\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0380\n",
      "http://refhub.elsevier.com/S0161-813X(18)30209-2/sbref0380\n",
      "\n",
      "\tDoes nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice\n",
      "\tIntroduction\n",
      "\tMaterial and methods\n",
      "\tAnimals\n",
      "\tDrugs and chemicals\n",
      "\tDrug treatment schedule\n",
      "\tDetection of tramadol in brain\n",
      "\tBiochemical measurements\n",
      "\tDetermination of cortical TBARS, NPSHs and NO contents\n",
      "\tDetermination of cortical TNF-α, NFκB, iNOS and nNOS\n",
      "\tDetermination of cortical monoamines and amino acids\n",
      "\tDetermination of cortical acetyl- / butyrylchloinestrases\n",
      "\n",
      "\tBehavioral tests\n",
      "\tOpen field test (OFT)\n",
      "\tSocial interaction test (SI)\n",
      "\tDefensive aggression test\n",
      "\tMorris Water Maze test (MWM)\n",
      "\n",
      "\tHistopathological examination\n",
      "\tImmunohistocemical examination of CD68, Casp-3 and TH\n",
      "\tStatistical analysis\n",
      "\n",
      "\tResults\n",
      "\tSurvival analysis and body weight change\n",
      "\tChanges in tramadol concentration in mice brain induced by concomitant administration of nicotine with tramadol\n",
      "\tAlterations in CD68 immunoreactivity induced by tramadol, nicotine and their combined administration\n",
      "\tEffect of nicotine on tramadol-induced alterations in cortical TBARS, NPSHs and NO contents in mice\n",
      "\tChanges in nNOS and iNOS induced by tramadol either alone or in combination with nicotine\n",
      "\tEffect of nicotine on tramadol – induced alterations in cortical NFκB, TNF-α as well as Casp-3 immunoreactivity\n",
      "\tChanges in cortical DA level as well as midbrain TH immunoreactitvity induced by tramadol either alone or in combination with nicotine\n",
      "\tChanges in cortical 5 H T and NE levels induced by tramadol either alone or in combination with nicotine\n",
      "\tChanges in cortical glutamate and GABA levels induced by tramadol either alone or in combination with nicotine\n",
      "\tEffect of tramadol either alone or in combination with nicotine on acetyl- and butyrylcholinestrases in cerebral cortex\n",
      "\tAlterations in spatial memory in the Morris Water Maze test consequent to tramadol administration either alone or in combination with nicotine\n",
      "\tInfluence of co-administration of nicotine with tramadol on aggressive behavior\n",
      "\tImpact of co-administration of nicotine with tramadol on social interaction test\n",
      "\tEffect of tramadol either alone or in combination with nicotine on assessment of anxiety-related behavior in OFT\n",
      "\tThigmotaxis time and central square frequency\n",
      "\tAmbulation and rearing frequencies\n",
      "\tGrooming frequency\n",
      "\n",
      "\tHistopathological changes in cortices of mice subject to tramadol alone or in combination with nicotine\n",
      "\n",
      "\tDiscussion\n",
      "\tConflict of interest\n",
      "\tReferences\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(pdf_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "colab": {},
    "colab_type": "code",
    "id": "s9XE3KV016-c"
   },
   "outputs": [],
   "source": [
    "#raw['metadata']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 54
    },
    "colab_type": "code",
    "id": "csjCypYG2LKz",
    "outputId": "4b10fb06-c167-4fbe-da26-11c754fd5bc3"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Shimaa M. Azmy', 'Mai A. Abd El fattah', 'Sahar S. Abd El-Rahman', 'Somia A. Nada', 'Omar M.E. Abdel Salam', 'Mohammed F. El-Yamany', 'Noha N. Nassar']\n"
     ]
    }
   ],
   "source": [
    "authors = raw['metadata'].get('meta:author','')\n",
    "print(authors)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 34
    },
    "colab_type": "code",
    "id": "OE7mIARb4Jkb",
    "outputId": "de8c5d6f-b5b3-4ba4-a7f5-c411ad8f8823"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2018-07-16T06:55:45Z\n"
     ]
    }
   ],
   "source": [
    "date = raw['metadata'].get('date','')\n",
    "print(date)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 34
    },
    "colab_type": "code",
    "id": "wUrI8XTB4ta3",
    "outputId": "61431f72-40bc-4f88-dd80-6316fa465874"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice\n"
     ]
    }
   ],
   "source": [
    "Title = raw['metadata'].get('title','')\n",
    "print(Title)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "colab": {},
    "colab_type": "code",
    "id": "467zkt2Y8dvP"
   },
   "outputs": [],
   "source": [
    "data=pd.DataFrame(columns=['date', \"pdf_text\",'Authors','Title'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "colab": {},
    "colab_type": "code",
    "id": "V0ZMipExkiE1"
   },
   "outputs": [],
   "source": [
    "#In case of multiple pdf files we can run the below loop and parse through them.\n",
    "#Each of the pdf file will create a new row.\n",
    "\n",
    "#for file in all_files:\n",
    "#  raw = parser.from_file(\"/content/drive/My Drive/Obama speeches pdf/\"+file)\n",
    "\n",
    "pdf_text=raw['content']\n",
    "date=raw[\"metadata\"].get(\"date\", \"\")\n",
    "date=date[0:10]\n",
    "authors = raw['metadata'].get('meta:author','')\n",
    "Title = raw['metadata'].get('title','')\n",
    "data=data.append({\"date\":date,\"pdf_text\":pdf_text,\"Authors\":authors,\"Title\":Title},ignore_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 77
    },
    "colab_type": "code",
    "id": "njIwTGsUlrEN",
    "outputId": "2d413c19-d036-4bb2-95fd-abcc8d6d9df7"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>pdf_text</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2018-07-16</td>\n",
       "      <td>\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n\\n...</td>\n",
       "      <td>[Shimaa M. Azmy, Mai A. Abd El fattah, Sahar S...</td>\n",
       "      <td>Does nicotine impact tramadol abuse? Insights ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         date  ...                                              Title\n",
       "0  2018-07-16  ...  Does nicotine impact tramadol abuse? Insights ...\n",
       "\n",
       "[1 rows x 4 columns]"
      ]
     },
     "execution_count": 51,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 77
    },
    "colab_type": "code",
    "id": "uU30qtRG8Xv4",
    "outputId": "db9f28f1-a296-49a6-e880-142d3c0d0988"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>date</th>\n",
       "      <th>pdf_text</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Title</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2018-07-16</td>\n",
       "      <td>Does nicotine impact tramadol abuse Insights f...</td>\n",
       "      <td>[Shimaa M. Azmy, Mai A. Abd El fattah, Sahar S...</td>\n",
       "      <td>Does nicotine impact tramadol abuse? Insights ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         date  ...                                              Title\n",
       "0  2018-07-16  ...  Does nicotine impact tramadol abuse? Insights ...\n",
       "\n",
       "[1 rows x 4 columns]"
      ]
     },
     "execution_count": 52,
     "metadata": {
      "tags": []
     },
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data[\"pdf_text\"].str.replace('[^A-Za-z\\s]+','') #1st half\n",
    "data[\"pdf_text\"] = data[\"pdf_text\"].str.replace('[^\\w\\s]','') #punctuations\n",
    "data[\"pdf_text\"] = data[\"pdf_text\"].apply(lambda x: ' '.join([w for w in x.split() if len(w)>2]))\n",
    "data.head()"
   ]
  }
 ],
 "metadata": {
  "colab": {
   "name": "PDF_converter.ipynb",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.6"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
